You asked for a mask
that would make a world of difference.
Together, we made it.
The supremely comfortable,
Every day, frontline workers have to deal with Personal Protective Equipment (PPE) that gets in the way of their comfort, their breathing, and their communication. Not to mention, disposables can create thousands of tons of waste each day and can cost hundreds or thousands of dollars per employee each year.
We knew there had to be a better way, so in April 2020 we assembled a team of scientists, industrial designers, and healthcare professionals from leading innovation centers to create a device that truly takes care of the people who take care of us.
Canopy is that next generation device, but it’s also so much more. It’s a pledge we can each make to the well-being of the people and places we love.
"Most comfortable ever."
A respirator should protect your face, not harm it. Canopy’s form-fitting, silicone seal is soft on your skin and snug on your face, guarding you from exposure without leaving that “bridge of honor” behind.
Specially-designed wings and an under-the-chin design maintain an air-tight seal, so you can show off your widest smile without worry.
Canopy is an injection-molded, sterilizable strap featuring a secure headpiece so comfortable you’ll forget it’s there.
>97% filtration. No exhalation valve.
From how we think to how we sleep, better breathing impacts all aspects of our well-being. Designed by a team with over 100 patents in filtration, Canopy’s patented 2-way filter has three times the surface area of a disposable N95, giving you the space you need to breathe easy.
See-through to show your smile.
Safety shouldn’t come at the cost of your sight or your smile. With Canopy’s transparent front lens and permanent anti-fog coat, you can interact with your patients, customers, friends, and family in a way that allows them to see and be seen.
Canopy will not fog your glasses.
Never buy another mask. Ever.
Disposable N95s are costly and wasteful. Converting to Canopy means you’ll spend considerably less on PPE while helping to eliminate to thousands of tons of landfill waste each year.
Canopy is constructed from feather-light yet ultra-strength materials that are simple to wipe down with common disinfectants. Each component is replaceable, and all models come with a one-year warranty, so you don’t have to worry about buying yet another respirator.
You told us everything to fix.
Canopy is all about the details. Each component of our respirator was developed based on direct feedback from frontline workers.
Created by scientists, engineers, designers, and healthcare professionals who studied and worked at leading research institutions and innovation centers
What users are saying
Canopy Pro Kit
The most comfortable mask ever. Two thumbs up!
Enough to buy one for my family members after getting mine! The Canopy mask is a benefit physically and emotionally.
--- Physically it is comfortable, effective, allows others to read my lips if needed, and does not fog eyeglass lens.
--- Emotionally I feel more relaxed because of the protection it offers
I have recommended it to others from the time I got mine.
This is the most comfortable mask I’ve ever used. The latches between the filter and the straps could be better in attaching to each other. Right now the filter comes off when I’m trying to wear it but once its on, it stays on.
The seal works well and you get nice flow of filtered data.
It's a miserable need, but living in a wildfire zone, it's become an annual thing to havfe to wear masks for extended periods (days) when air quality is poor due to nearby (or sometimes not so nearby) fires. The Canopy is super comfortable with a long-lasting filter. We're happy to have found them.
I couldn't be happier. This is so much more comfortable than the disposable N95s.
We’re a tiny, ultra-low-budget indie film production company following SAG Covid safety rules. Masks are essential for our behind-the-camera crew—but our brilliant director is hearing impaired and reads lips. We’ve gotten Canopy masks for our dept heads and on-set production team—perfect for our needs! We’re still in pre-production—we’re filming in April and May, and we’ll report back with an on-location update! Canopy has been beyond great in providing info and swiftly handling a SNAFU created by the shipping company. We can’t wait to share our behind-the-scenes photos of the crew and production team wearing their masks!
Love my canopy. It’s comfy and comforting. I don’t doubt the seal or the mask’s effectiveness like I do regular n95s. It’s big and attracts attention but after a friendly exchange, some people have expressed curiosity about cost and availability. I teach in mine and it’s fine for long days. Highly recommended for anyone who wants the best protection and doesn’t mind standing out a bit.
This mask is exactly as described-- comfortable, does not cause my glasses to fog. I am thrilled and only wish that I had had it before. Thank you for such an excellent product
A nice mask
Love the canopy mask! I was skeptical as I literally found it while googling for a see through mask since I have older patients who read lips. Purchased this on a whim but wanted to be certain that it does what it says. It is VERY easy to breathe in. It also is easy to don and doff. It seems bulky but patients really appreciate being able to read my lips and seeing my face.
To be safe, I had contacted a company here who does mask fitting (CIMRO). I passed two N95 masks - the 3M Aura 1870 and the Dentx 2020H Plus. It was done with a portacount. While the other two passed, the canopy were the best fitted and passed with flying colors, even when moving my head, talking loudly, and bending.
It is bigger than regular N95, so I store it in a small Dollarama clear plastic box with a handle and it fits perfectly.
A few key points, I would recommend having 2 masks. It seals so well so there is accumulation of moisture if you are talking all day, so it does slip down the nose a bit if I use it for an entire day but the seal remains intact, just not as comfortable as when at the beginning of the day. So I do use one per half day just as I do with regular N95. This is so it has time to dry. You will have to bend your head more to see your fingers when you type. So this happens when I can't find my computer mouse. But I do small procedures all day and can see easily and my neck feels great. It is very light. My goggles did not fog at all, so you know the seal is working. With the 3M Aura, even though it passed the mask fit test, after a few hours, the seal doesn't hold and my goggles do fog.
Overall very happy and would highly recommend it.
I am giving the Canopy high marks. It has P2 level protection yet only very minimally reduces vocal clarity compared to other elastomeric masks which severely muffle your speaking voice. Of all of the elastomerics I have tested for preservation of vocal output (measuring dB output) the Canopy is easily the best. The transparent front allows hearing impaired patients to lip read and is even better in this regard than my Halo PAPR elastomeric. It has none of the confronting gas mask like look found on many elastomeric P3 respirators like those from 3M and Sundström. It is extremely comfortable, comparable in level to my Dräger X-Plore 2100 P3 respirator, only more aesthetically pleasing and socially acceptable. It does not accumulate condensation inside as some elastomerics are prone to. It is easy to don and doff. This futuristic design is thus a clear winner in my books and I can say that with confidence now I have tested and worn quite a few elastomerics. My only wish is that the NIOSH approval will come through soon making it more acceptable to OH&S in hospitals to give the go ahead for HCWs to wear this. So until then I will be using it as my everyday mask outside of the hospital (once the NIOSH approval comes through I might consider it in low risk clinical settings if case numbers are low, otherwise I am sticking to the PAPR when seeing COVID patients). Other than that the thorough external laboratory testing results made available are more than enough reassurance of safety even without official NIOSH approval. The Canopy may cost a bit more upfront but it is reusable and more environmentally friendly than disposable masks. I can see it having high social acceptability amongst medical clerical staff (elastomerics have been shown in studies more comfortable than N95 masks and stop your glasses fogging because you get an immediately superior fit/seal in +90% of subjects), nursing/medical staff and patients.
Best respirator I had. When using make sure it is all fully joined together before putting on. Its parts hold together very. Flomask has a better breathable bag than canopy but this is okay. I keep canopy filter part in my flomask bag to make sure no crumbs from anywhere get into filter when not in use. I do stick out with this mask but felt surprisingly okay about it once I actually wore it. Great design. I am in love with it. Just so good that these people went through all this effort and made this life saver. Does not get too wet in there either. Extremely good fit for my face. I sometimes wear a fleece hat under the calo strap but even without the fleece I like the strap enourmously. Much more than too flexible straps. A tupperware box with holes can be good to protect the respirator when tucked in my backpack. I was recommended this mask by Nicolas from twitter.com/ppeToHeros. I trust him on anything and he was right as always about how good this mask is. My daughter can see my mouth when I talk through the mask to her. I never liked a product so much before except for my child's flomask. I keep the product info with me in case someone needs proof that this mask is nonvalved. If I am asked to wear a throw-away mask, I always have an Aura ready around my neck.
Fits snug to face, over my goatee. No more fogged glasses.
People see my smile again, puts them at ease.
They get the jokes & quips again.
The mask is extremely comfortable and has a great seal. Breathing is also very effortless and feels secure. The mask also appears to be well constructed and I look forward to using it in the future.
Built by an experienced and entrepreneurial team.
Prior to Canopy, Kim led Apollo Global Management's $20B high growth Pension Risk Transfer (PRT) business for its insurance unit, Athene. Kim had P&L accountability and oversight of all key functions.
During her tenure, Kim took the business to number one in the market, writing a record $5.5B of new business in 2020.
Kim structured and closed several landmark transactions, including with GE ($2B) and JCPenney ($3.2B). Kim also sat on the board of the women’s Employee Resource Group (ERG) as a Diversity, Equity & Inclusion leader, and as a sponsor of underrepresented talent.
Prior to joining Athene, Kim was one of four founders of $1.2 trillion asset manager Legal and General Group’s US PRT business where she served as Head of Distribution since its 2015 market launch. Kim led sales, marketing, client solutions, business strategy and leadership development growing the business to nearly $4 billion in assets and 50 employees within five years. She previously served as Deputy Head of Distribution for Legal & General Investment Management America business where she worked with corporate pension and insurance clients to implement liability-driven investment and fixed income strategies. Her leadership contributed to nearly $50B of asset growth during her tenure.
Prior to Legal & General, Kim started her career at MBIA Asset Management. Her final role was as a Director where she led the development of pension de-risking strategies and insurance solutions for institutional clients. Prior she helped guide MBIA through the financial crisis, then pivot the business to a retirement solutions platform. Pre-financial crisis she led asset/liability risk management for a $30B bespoke lending business.
Kim holds a Bachelor of Business Administration in public accounting and an honors degree from the Pforzheimer Honors College at Pace University where she graduated magna cum laude. She also holds a Master of Business Administration from Marist College.
From 2010-2018, Joe was a founding team member of Google Shopping Actions, the company’s expansion into verticalized search for retail. He focused on partnership development and management with the country’s largest retailers and fintech providers to implement shared omni-channel distribution strategies in an effort to mitigate Amazon’s market dominance. Joe has an uncanny ability to inspire and motivate partners, clients and team members alike with his cutting-edge ideas and approaches to business development implementing change at large institutions.
Joe has structured first-of-their-kind partnership deals between Google and organizations in both the retail and financial services industries, including negotiating agreements impacting more than $1B of Google e-commerce transaction volume.
Joe left Google in 2018 to pursue entrepreneurial endeavors. He is the co-founder of Subject to Change Wine Company, a globally distributed natural winery based in California. He earned a BA with honors from the Gallatin School at NYU in 2010.
Supported by expert partners, advisors, and collaborators
Lisa Brosseau, ScD, CIHIndustrial Hygiene
Dr. Brosseau is among the world’s most cited scholars on Respiratory Protection. She is a consultant to the National Institute for Occupational Safety and Health (NIOSH) and the University of Minnesota Center for Infectious Disease Research and Policy (CIDRAP). Past clients have included 3M, Ontario Nurses Union, Manitoba Nurses Union, UAW, National Education Association, OSHA, Moldex, TSI, Inc., and the CDC.
Lisa is certified by the American Board of Industrial Hygiene and Associate Faculty of Occupational Hygiene in the British Occupational Hygiene Society with a focus on respiratory protection, aerosol measurement, filtration performance, and small business health and safety.
Elizabeth Clayborne, MD, MAEmergency Medicine / Bioethics
Dr. Clayborne attended Duke University as an undergraduate where she designed her own major in Medical Ethics and Religion. Prior to medical school she completed a two-year research fellowship at National Institutes of Health in the Social and Behavioral Research Branch of the National Human Genome Research Institute with a research focus on race, ethnicity and genetics. Dr. Clayborne attended to medical school at Case Western Reserve University where she completed a dual MD/MA Bioethics degree in 4 years.
She went on to complete residency in Emergency Medicine at the George Washington University Hospital and served as Chief Resident in her fourth year. Dr. Clayborne is currently a faculty member at the University of Maryland School of Medicine Department of Emergency Medicine with an academic focus on ethics, health policy, end of life care, health disparities and innovation/entrepreneurship. She developed a novel epistaxis device bleedfreeze.com as a resident and in 2015 was awarded the NSF I-Corps grant which helped to launch her company Emergency Medical Innovation, LLC. She is the former Chair of the MedChi Committee on Ethics and Judicial Affairs, serves on the Ethics Committee of the American College of Emergency Physicians and is an active member of the Society of Academic Emergency Medicine, the American Medical Association and the National Medical Association.
Marty GlickInvestor and Advisor
Marty is an accomplished biotech and medical device entrepreneur and executive. He was co-founder and chairman of the board of PEAK Surgical, a medical device company acquired by Medtronic. He also co-founded Eyetech Pharmaceuticals (IPO) and was EVP and CFO of Theravance leading up to their IPO. Marty began his biotech career as a leader in Genentech’s finance organization from 1987-1997.
Marty is a CPA and Chartered Accountant (Ontario, Canada) and holds an MBA in Finance at Kellogg School of Management at Northwestern University.
Marty is in his eighth season with the Golden State Warriors, his sixth as special advisor to ownership. In this capacity, Glick is primarily responsible for advising ownership on major strategic issues including the development of the Chase Center, the team’s state-of-the-art sports and entertainment center and other major strategic initiatives such as the team’s COVID-19 response. He is also a board member for the Warriors Community Foundation.
Prior to assuming his current role in the summer of 2013, Glick served two seasons as chief financial officer for the Warriors, overseeing all financial strategy, planning and accounting for the organization. He is also a minority owner.
Tom Gsell, PhDMaterial Science
Over a span of 36 years, Tom helped grow Pall Corporation into a lead innovator in the field of high-tech filtration. He held R&D leadership positions in increasing responsibility, and appointment to Senior Corporate Vice President in 1996.
Tom’s career led to senior level management responsibilities including global leadership of Materials R&D for both the Pall Industrial and Life Sciences (Medical) divisions. During his tenure Pall’s revenues and profits grew rapidly, fueled by new product innovation made in part possible by the teams under Tom’s purview.
Tom is named as a co-inventor on approximately hundreds granted and published US and International patents, as well as a number of peer reviewed scientific publications.
Narissa Joyner, MDEmergency Medicine
Dr. Joyner is an attending physician in Emergency Medicine at Lenox Hill Hospital in New York City. She completed her training in emergency medicine at Morristown Medical Center Regional Trauma Center in Morristown, NJ. Upon board certification in emergency medicine, she began her independent career with Northwell Health.
Dr. Joyner serves on the Board of Governors for Physician Partners at Northwell Health and is an active member of the American College of Emergency Physicians, the Society of Academic Emergency Medicine, the American Medical Association, the National Medical Association and the Medical Society of the State of New York- Young Physician Section. She is a clinical advisor to Canopy, having served on the front lines of the COVID-19 Pandemic at Lenox Hill Hospital for its duration.
Dr. Joyner provides product development guidance and clinical feedback to Canopy, and has been instrumental in creating a clinical advisory group for Canopy’s product development.LinkedIn Northwell Health profile
Abraar Karan, MD, MPH, DTM&HInfectious Disease / Epidemiology
Dr. Karan is an infectious diseases fellow in the Division of Infectious Diseases and Geographic Medicine with interests in emerging infections, infectious disease epidemiology, and global health equity.
Karan completed his residency in internal medicine at the Brigham and Women's Hospital and Harvard Medical School, and as a graduate of the Doris and Howard Hiatt Residency in Global Health Equity. He earned his MD from the UCLA David Geffen School of Medicine where he served as Student Body President; an MPH from the Harvard T.H. Chan School of Public Health; a Diploma in Tropical Medicine and Hygiene (DTM&H) from the London School of Hygiene and Tropical Medicine; and his undergraduate degree w/ distinction from Yale University in political science, where he was a Yale Journalism Scholar.
From February to October 2020, Dr. Karan worked on COVID19 response for the state of Massachusetts as a medical fellow to Dr. Monica Bharel, MA Commissioner of Public Health. From November to January 2021, he worked as a research consultant to the WHO commissioned Independent Panel for Pandemic Preparedness and Response on Covid-19 epidemiology. He also served as a research assistant for the Harvard College Fall course on Covid-19 and epidemics. Furthermore, Karan was involved in the Biden-Harris campaign's Covid-19 policy writing for school reopenings. Prior to this, Dr. Karan studied epidemic response and emerging infectious diseases, with a focus on rural pathogens, including Ebola. In 2018, Abraar co-founded Longsleeve insect repellent, winner of the 2018 Harvard Business School New Venture Competition and a finalist in the 2019 Harvard President's Challenge, which strives to have a notable impact on curbing transmission of vector-borne epidemic outbreaks. Karan also led the American Medical Association's Journal of Ethics theme issue on pandemic response, published in January 2020; and he is a peer-reviewer for the CDC's Emerging Infectious Diseases Journal.
Dr. Karan's previous work over the past 13 years has included various projects in Latin America (Mexico, Honduras, Nicaragua, Haiti, Dominican Republic), Asia (India, Thailand), and Sub-Saharan Africa (Rwanda, Uganda, Mozambique). In 2011-2012, as a Yale Parker Huang Fellow, Karan conducted an anthropological research study in India exploring sex trafficking and intergenerational sex work in Hyderabad and Delhi. He is also interested in the intersection between medical ethics and global health (particularly neocolonialism). Abraar participated as a medical fellow in Auschwitz studying the history of the Holocaust for the FASPE program in 2016; and led the AMA Journal of Ethics twice (2016-17 on international healthcare systems; 2019-20 on pandemic response).
Since January 2019, Dr. Karan has also been a columnist at the British Medical Journal. Prior to that, he co-edited the book, "Protecting the Health of the Poor", which was published in December 2015. He has authored works in the NEJM, The Lancet, The BMJ, Academic Medicine, Health Affairs, NPR, WaPo, Vox, Los Angeles Times, CNN, Scientific American, Huffpost, Boston Globe, Harvard Business Review, and other major publications. Press coverage has included: NBC, ABC, BBC, PBS, CBS, CNN, MSNBC, Washington Post, New York Times, Bloomberg, Boston Globe, ProPublica, WSJ, TIME, TMZ, Science Friday, Medium, The Verge, Politico, CBC News, MTV News, Democracy Now, NPR, ESPN, The Atlantic, The Hill, Business Insider, Vice, Mother Jones, Boston Magazine, Vox, Healthline, Forbes, Slate, STAT News, Harvard Public Health Magazine (cover story Spring 2020), and others
David NarrowBusiness Advisor
David Narrow is co-founder and CEO of Sonavex Inc., a venture-backed commercial stage medical device company spun-out of Johns Hopkins University, which has raised over $14M. The company develops and commercializes ultrasound products for surgeons, including a technology for detecting post-operative vascular complications.
David previously worked with multinational medical device companies to commercialize their technologies and provide long-term business strategy as a healthcare consultant at Health Advances LLC. Narrow earned his B.S. in Biomedical Engineering with Highest Distinction from the University of Rochester before receiving his Masters from Johns Hopkins University. He was named 30 Under 30 in Healthcare by Forbes in 2016, 40 Under 40 by the Baltimore Business Journal in 2017, and recognized as Baltimore’s Top BioHealth Startup CEO in 2019.
Governor Peter ShumlinGovernment Relations / Public Health
Governor Peter Shumlin served three terms as the 81st governor of the state of Vermont. He was a member of the Vermont House of Representatives from 1990 to 1993, and served as State Senator for the Windham County from 1993 to 2003 and from 2007 to 2011, and he was elected president of the senate for 10 of those years. Shumlin served as the chair of the Democratic Governors Association during his first two terms.
During his time in office, Governor Shumlin established Vermont as a leader on progressive policies, making the state the first to guarantee universal pre-kindergarten education for all 3 and 4-year-old children, pass a mandatory GMO labeling law, and achieve near universal healthcare coverage with the lowest rate of uninsured in the country. Under his leadership, Vermont consistently ranked among the top states in solar energy jobs per capita and enacted a number of laws to boost renewable energy production and combat climate change. Because of Vermont’s leadership, Governor Shumlin was invited by President Obama to the Paris Climate Summit to push for a global climate agreement.
Governor Shumlin turned the nation’s eyes to the problem of opiate and heroin addiction by dedicating his entire 2014 State of the State Address to the issue and pushing for policies to treat addiction as the healthcare crisis that it is.
A committed entrepreneur, Shumlin is the longtime co-director of Putney Student Travel, National Geographic Student Expeditions, and Smithsonian Student Travel, sending high school age students on educational programs and service projects across the globe. He is a Director of The Scotts-MiracleGro Company, has served as a visiting fellow at the Harvard Kennedy School of Government, and has taught at the Harvard Chan School of Public Health as the Menschel Senior Leadership Fellow.
Rick SmithInvestor and Advisor
A pioneer of technology with the vision of making the bullet obsolete, Rick founded the original company, TASER, in 1993. As the TASER device became ubiquitous in law enforcement, Rick pushed the company beyond weapons technology and towards a broader purpose of matching technology to public safety needs in order to make the world a safer place. Under his leadership, the company has grown from a garage in Tucson to a NASDAQ-listed global market leader in conducted electrical weapons, body worn cameras and software. Rick was winner of the Ernst and Young 2002 Entrepreneur of the Year. Rick graduated from Harvard with a B.S. in Neuroscience (Cum Laude) and later earned a Master in International Finance from the University of Leuven in Belgium and an MBA from the University of Chicago.LinkedIn
John StrongHealthcare Supply Chain
In his role with ASPI, John works with medical device manufacturers and medical products and technology companies on strategic planning, sales, education, marketing, national accounts strategy and more.
John is a 40-year veteran of the healthcare industry, with leadership experience in healthcare providers, suppliers and service providers, and group purchasing organizations. In 2011 the Bellwether League (Health Care Supply Chain Hall of Fame) inducted John for “his outstanding contributions over the years to healthcare supply chain management, development, innovation and leadership."
John has developed and implemented programs that have generated hundreds of millions of dollars in value for his employers and clients. Prior to co-founding ASPI in 2018, John served as president of Greenhealth Management, a subsidiary of Practice Greenhealth. It operates Greenhealth Exchange, which is focused on developing specifications and aggregating green, sustainable purchasing volume to accelerate the adoption of better and more sustainable products in the healthcare industry. He also held executive leadership positions with Nexera, Inc. a wholly owned subsidiary of the Greater New York Hospital Association, where he was Senior Vice President of Management Services and served as the founding President and Chief Executive Officer of Consorta, a $5 billion-dollar group purchasing organization serving more than 350 hospitals.
He participated in the development of programs providing more than $500 million in value to Consorta’s owners during his more than ten-year tenure. John also served in a number of senior executive positions at Premier, Inc., where he was a key architect of Premier’s contracting programs, member service and marketing operations for the group purchasing program, increasing purchasing volume more than eight-fold.LinkedIn
Kwame UlmerFDA Regulatory Affairs
Mr. Ulmer led Regulatory Affairs and Quality Assurance for Danaher Corporation. Prior to that he spent 12 lears at the FDA, retiring as Deputy Director. He has reviewed over 1,000 new medical devices and technologies.
Kwame holds a Masters in Materials Engineering and a MBA from University of Virginia.LinkedIn
Jim WalkerInvestor and Advisor
Jim has more than 30 years of professional experience in Sales, Marketing, Sales Operations and National Accounts management in the medical device sector. His experience spans both domestic and international responsibilities, with a focus on strategic market development and key customer management.
In Jim’s 18-year tenure as a sales executive with Boston Scientific Corporation (BSC), he established the company as a recognized leader with Group Purchasing Organizations and created a world-class Corporate Sales organization that represented the full BSC portfolio to supply chain executives across every level of market aggregation, including Group Purchasing Organizations, National and Regional Integrated Delivery Networks, and National and Regional Purchasing Alliances. He was the lead strategic pricing advisor for the company and gained the support of the executive management team to invest in and develop an enterprise-wide contract management system that provides global pricing intelligence and profitability analysis capabilities.
Jim served on the company’s Operating Committee and advised BSC international executives on strategies for managing market globalization and the increasing focus on economic value. He also served on the GHX Board of Directors and on their European President’s Council through 2012.
Early in his career Jim had a successful tenure with Johnson & Johnson as Director of Sales of the Orthopedic Implant division and of the Hospital Services division. Prior to founding ASPI in 2018, Jim successfully represented numerous device companies with major U.S and Global customers and also consulted to SMI, an industry collaborative of major U.S. IDN Supply Chain Executives. Jim holds a B.S. in Education from Northeastern University.LinkedIn
Jim WeissInvestor and Advisor
Jim Weiss is the founder and chief executive officer of W2O, the leading independent provider of analytics-driven, digital-first marketing and communications to the healthcare sector.
Over the years, Jim has often been recognized as one of the most influential people in health communications and PR. Some of his many accolades include 500 Most Important People in the Global PR Industry (2015, 2017), PRWeek’s Power List (2012, 2013, 2014, 2019, 2020), Innovator of the Year (2020), Top 50 Health Influencer (2016, 2017, 2018, 2019) and Top 25 Innovator in Communications (2014). He was inducted into the Hall of Fame at the Newhouse School of Public Communications at Syracuse University, his alma mater, and honored as one of its 50Forward most accomplished graduates of the last 50 years.
Jim, with his wife Audra, founded the W2O Group Center for Social Commerce at the Newhouse School. Viewed as one of the most successful industry/academic partnerships, the Center provides students with modern media analytics and digital insight and skills to set them apart from their peers.
Inspired by a commitment to diversify the workforce, Jim partnered with Kim Hunter at The LAGRANT Foundation (TLF) to form the first-of-its-kind paid healthcare fellowship, which places multicultural minorities pursuing careers in healthcare communications in a W2O office. He sits on the TLF’s Board of Directors.
With 30 years of experience in strategic media and marketing communications in the healthcare and technology sectors, Jim has been involved in nearly every aspect of corporate, product and organizational communications. Before starting his own firm, he was head of corporate communications and investor relations at medical device start-up Heartport, a pioneer in minimally invasive cardiac surgery. Prior to that, he helped establish the global product marketing communications function at pharmaceutical giant Sanofi in Paris. He started his corporate career at biotechnology bellwether Genentech during its formative commercial years in the early 1990s.
Jim is on the Board of Trustees of the Cancer Research Institute and The Commons Project and is an Advisory Board member of the Newhouse School and the Healthcare Businesswomen’s Association.
Jim resides with his wife and two children in the San Francisco Bay Area, where W2O is headquartered.
Canopy for everyone.
One crisis should not give rise to another. While we’re dedicated to protecting the health of people around the world, it’s equally important to us that we take care of the planet we all call home. A commitment to Canopy is a commitment to the well-being of the people and places we love.
CANOPY IS PROUD TO HAVE ATTAINED PENDING B CORP STATUS AND DIRECTLY SUPPORTS 9 OF THE 17 U.N. SUSTAINABLE DEVELOPMENT GOALS.
OUR FORTHCOMING 501(C)(3) NONPROFIT WILL PARTNER WITH LEADING NGOS, GOVERNMENTS, AND PUBLIC HEALTH ORGANIZATIONS TO DISTRIBUTE CANOPY RESPIRATORS TO POPULATIONS IN NEED, BOTH DOMESTIC AND ABROAD. UNTIL THEN, WE FORMALLY COMMIT TO DONATE 2% OF REVENUES TO CHARITABLE PARTNERS EACH YEAR (INCLUDING IN KIND PRODUCT DONATIONS).
MADE IN THE USA WITH US AND GLOBALLY SOURCED COMPONENTS